Quantcast
 
Read Larry Connors' blogShort Term Trading Strategies


 

Hygiene product makers cash in on swine flu outbreak

Thu. September 24, 2009; Posted: 11:06 AM
Stocks RSS
PUNE, India, Sep 23, 2009 (The Economic Times - McClatchy-Tribune Information Services via COMTEX) -- RBGPF | Quote | Chart | News | PowerRating -- The recent swine flu scare has translated into brisk business for health and hygiene sectors. While branded products like Dettol saw a rise in their sales, even local ayurvedic drug manufacturers are marketing their products as protection against the H1N1 virus.

After the flu outbreak, products like eucalyptus oil, homeopathy medicines and disinfectants like Dettol, liquid hand wash and soaps were in great demand. As a senior official from Reckitt Benckiser, global FMCG company and maker of Dettol, puts it: "Demand for our products in this category has risen 40-45 percent in the past two months in Maharashtra."

After the first few swine flu fatalities, there was a sudden rush to buy personal hygiene products. Kavita Yogesh Kode, owner of a local medical store, said: "Earlier, people did not know much about hand sanitisers. I used to sell one bottle a month. Now, sales are up and I sell about 20 bottles a day." While some local companies have launched new brands of hand sanitisers, others have re-launched their old brands.

Swine flu panic also helped in pushing up sales of several ayurvedic products. After some ayurveda practitioners emphasised that extracts of certain herbs like tulsi, bel ahwagandha etc and burning of camphor may help against the spread of H1N1 virus, demand for these herbs also went up.

Sachin Vetankar, another medical store owner, said: "We have seen a five to six fold increase in the sale of eucalyptus oil. Against a weekly sale of about 3-4 bottles before the outbreak of swine flu, I sold about 50 bottles every day when the scare was at its peak. Now, I sell at least 10 bottles everyday."

In Pune, which saw the highest number of swine flu deaths, the protective N95 and N90 masks were being sold at exorbitant rates in the black market. "Currently, we are selling the N95 mask for Rs 100. But, after the first swine flu death in Pune, these masks were sold at Rs 300-Rs 400 per piece," said a medical store owner.

To see more of The Economic Times, or to subscribe to the newspaper, go to
http://economictimes.indiatimes.com Copyright (c) 2009, The Economic Times,
India Distributed by McClatchy-Tribune Information Services. For reprints, email
tmsreprints@permissionsgroup.com, call 800-374-7985 or 847-635-6550, send a fax
to 847-635-6968, or write to The Permissions Group Inc., 1247 Milwaukee Ave.,
Suite 303, Glenview, IL 60025, USA.
For full details for RBGPF click here.

    


More News:   Market Updates | Stock Alerts | All Trading News | Stock Index

Email
Print
Archives
Feedback
Email Article Link
Close X
Recipients email address
Your name
Your email
Add a note (optional)




Stocks RSS





Related News [RBGPF]
  UPCOMING EVENTS
Learn new strategies, how to trade in this market, and the stocks you should be focusing on each day. Join us for our free 20 minute tele-seminars during the week.
* Attendance is strictly limited and are filled on a first-come, first-served basis.
PREMIER SPONSORED LINKS
TRADE CENTER
 
The TradingMarkets Directory
RELATED SITES
Nothing but forex
Please call 1-213-955-5858 ext. 1

About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback

Disclaimer:

The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.

It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.

HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.

The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302

© Copyright 2009 The Connors Group, Inc.


All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.

© 2009 The Connors Group, Inc.